{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:44:59Z","timestamp":1777434299188,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"R.U.O.T.A."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.lfs.2018.11.002","type":"journal-article","created":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T09:35:48Z","timestamp":1541324148000},"page":"80-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Acyclovir induces cell cycle perturbation and apoptosis in Jurkat leukemia cells, and enhances chemotherapeutic drug cytotoxicity"],"prefix":"10.1016","volume":"215","author":[{"given":"Serena","family":"Benedetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9836-1821","authenticated-orcid":false,"given":"Francesco","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Canonico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Luchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Galati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Papa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serafina","family":"Battistelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.11.002_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1750-9378-7-33","article-title":"Using antimicrobial adjuvant therapy in cancer treatment: a review","volume":"7","author":"Alibek","year":"2012","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.lfs.2018.11.002_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tiv.2017.02.008","article-title":"Reduced cell viability and apoptosis induction in human thyroid carcinoma and mesothelioma cells exposed to cidofovir","volume":"41","author":"Catalani","year":"2017","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.lfs.2018.11.002_bb0015","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-10-2334","article-title":"Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer","volume":"17","author":"Pettersson","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jmv.1890410503","article-title":"Acyclovir: discovery, mechanism of action, and selectivity","volume":"41","author":"Elion","year":"1993","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(82)90054-7","article-title":"Acyclovir chemistry and spectrum of activity","volume":"73","author":"Schaeffer","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.lfs.2018.11.002_bb0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMc1302145","article-title":"Survival in patients with glioblastoma receiving valganciclovir","volume":"369","author":"S\u00f6derberg-Naucl\u00e9r","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2018.11.002_bb0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ijc.28111","article-title":"Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study","volume":"133","author":"Stragliotto","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2018.11.002_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-2094-7-44","article-title":"Acyclovir inhibition of IDO to decrease Tregs as a glioblastoma treatment adjunct","volume":"7","author":"S\u00f6derlund","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2018.11.002_bb0045","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.lfs.2006.11.031","article-title":"Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid","volume":"80","author":"M\u00fcller","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2018.11.002_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11523-017-0547-9","article-title":"Modulating tumor immunology by inhibiting indoleamine 2,3\u2011dioxygenase (IDO): recent developments and first clinical experiences","volume":"13","author":"Davar","year":"2018","journal-title":"Target. Oncol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0055","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1158\/1078-0432.CCR-11-1331","article-title":"Indoleamine 2,3\u2011dioxygenase expression in human cancers: clinical and immunologic perspectives","volume":"17","author":"Godin-Ethier","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jmgm.2016.12.018","article-title":"Antiviral drug acyclovir exhibits antitumor activity via targeting \u03b2TrCP1: molecular docking and dynamics simulation study","volume":"72","author":"Shafique","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.lfs.2018.11.002_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-017-0128-7","article-title":"The effects of antiviral treatment on breast cancer cell line","volume":"12","author":"Shaimerdenova","year":"2017","journal-title":"Infect. Agent. Cancer"},{"key":"10.1016\/j.lfs.2018.11.002_bb0070","article-title":"Complete remission of acute myeloid leukemia following cisplatin based concurrent therapy with radiation for squamous cell laryngeal cancer","volume":"2016","author":"Mody","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ejh.12274","article-title":"Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide","volume":"92","author":"Lee","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1756-9966-32-63","article-title":"Metabolism modifications and apoptosis induction after Cellfood\u2122 administration to leukemia cell lines","volume":"32","author":"Catalani","year":"2013","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2018.11.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172138","article-title":"Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts","volume":"12","author":"Catalani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.11.002_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-0934(00)00244-5","article-title":"A quantification of human cells using an ERV-3 real time PCR assay","volume":"91","author":"Yuan","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.lfs.2018.11.002_bb0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-3542(95)00066-6","article-title":"Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy","volume":"28","author":"Beutner","year":"1995","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0105","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00003495-198326050-00002","article-title":"Acyclovir: a review of its pharmacodynamic properties and therapeutic efficacy","volume":"26","author":"Richards","year":"1983","journal-title":"Drugs"},{"key":"10.1016\/j.lfs.2018.11.002_bb0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/10799900050023870","article-title":"Inhibitory effects of IFN-gamma and acyclovir on the glioblastoma cell cycle","volume":"20","author":"Kominsky","year":"2000","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0145-2126(96)00009-4","article-title":"Inhibitory effect of a nucleoside analog, acyclovir, on leukemia cells","volume":"20","author":"Nishimaki","year":"1996","journal-title":"Leuk. Res."},{"key":"10.1016\/j.lfs.2018.11.002_bb0120","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1128\/JVI.02423-10","article-title":"Consistent inhibition of HIV-1 replication in CD4+ T cells by acyclovir without detection of human herpesviruses","volume":"85","author":"McMahon","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd4010","article-title":"Advances in the development of nucleoside and nucleotide analogues for cancer and viraldiseases","volume":"12","author":"Jordheim","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2018.11.002_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2018.11.002_bb0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00280-016-3054-2","article-title":"Therapeutic drug monitoring of 5\u2011fluorouracil","volume":"78","author":"Lee","year":"2016","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518307070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518307070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:16:23Z","timestamp":1758399383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518307070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"alternative-id":["S0024320518307070"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.11.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acyclovir induces cell cycle perturbation and apoptosis in Jurkat leukemia cells, and enhances chemotherapeutic drug cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}